Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings Of The Fortnight: Could California’s Regenerative Medicine Ballot Initiative Pass Today?

This article was originally published in The Pink Sheet Daily

Executive Summary

Plus news on recent financings by bluebird bio, Puma Biotechnology, Atara Biotherapeutics and Aclaris Therapeutics.

Advertisement

Related Content

Vicept Management, VCs Team Up Again To Launch Aclaris With $21M
Former Yaupon Therapeutics Raises $15 Million In Debt To Prepare To Commercialize Its First Product
J&J’s Zytiga –The Anatomy Of A Cancer Launch
After Complex Sale, Amira Scientist And VC Team Up Again For Discovery Start-up
Vicept Acquired By Allergan For $75M Upfront

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS073521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel